{"disease":{"id":"uterine-septum","name":"uterine septum"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03880435","title":"HYALOBARRIER® GEL ENDO Versus no HYALOBARRIER® GEL ENDO Following Operative Hysteroscopy for Improving Reproductive Outcome in Women With Intrauterine Pathology Wishing to Become Pregnant","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":419,"lead_sponsor_name":"University Hospital, Ghent","has_results":false},{"nct_id":"NCT05139446","title":"Reproductive Outcomes Following Uterine Septum Resection","phase":"","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT06315582","title":"Surgical Approach to Uterine Septum","phase":"NA","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Northwestern University","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}